Jyong Biotech Ltd. Ordinary Shares (MENS)
MENS Stock Price Chart
Explore Jyong Biotech Ltd. Ordinary Shares interactive price chart. Choose custom timeframes to analyze MENS price movements and trends.
MENS Company Profile
Discover essential business fundamentals and corporate details for Jyong Biotech Ltd. Ordinary Shares (MENS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
17 Jun 2025
Employees
31.00
Website
https://www.jyongbio.com/CEO
Fu-Feng Kuo
Description
Jyong Biotech Ltd. is a Taiwanese biotechnology enterprise dedicated to the research, development, and market introduction of botanical therapeutics, specifically aimed at addressing diseases of the urinary system. Its operations are orchestrated through various subsidiary entities, including Health Ever Bio-Tech and Genvace. The company is actively advancing a robust pipeline of drug candidates, which notably features MCS-2, currently undergoing Phase III trials for benign prostatic hyperplasia (BPH); PCP, which is in Phase II development for prostate cancer; and IC, presently in pre-clinical stages.
MENS Financial Timeline
Browse a chronological timeline of Jyong Biotech Ltd. Ordinary Shares corporate events including earnings releases, dividend announcements, and stock splits.
MENS Stock Performance
Access detailed MENS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
